A decade later, there are still major issues to be addressed in paediatric anaesthesia

Walid Habre1, Nicola Disma2

  • 1Paediatric Anaesthesia Unit and Unit for Anaesthesiological Investigations, Department of Anaesthesia, Pharmacology, Intensive Care and Emergency Medicine, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

Insights

Advances in pediatric anesthesia focus on airway management and analgesia, shifting research from neurotoxicity to anesthetic conduct. Evidence-based practices and patient-centered outcomes are crucial for improving pediatric anesthesia safety and efficacy.

Area of Science:

  • Pediatric Anesthesiology
  • Perioperative Medicine
  • Evidence-Based Practice

Background:

  • Paediatric anaesthesia management has seen advances, yet critical questions remain unanswered.
  • Research focus is shifting from anaesthetic agent neurotoxicity to anaesthesia conduct.
  • Standardization of airway management, analgesia, and outcome measures are key challenges.

Purpose of the Study:

  • To review recent advances in paediatric anaesthesia management.
  • To highlight improvements in airway management and analgesia techniques.
  • To emphasize the importance of evidence-based practice and patient-centered outcomes.

Main Methods:

  • Review of recent systematic reviews and clinical practice trends.
  • Analysis of improvements in airway management (videolaryngoscopes, nasal oxygenation).
  • Discussion of the increasing use and challenges of dexmedetomidine.

Main Results:

  • Videolaryngoscopes and nasal oxygenation have improved neonatal and infant airway management.
  • Dexmedetomidine use is increasing, presenting potential challenges.
  • Many current clinical techniques lack robust evidence for efficacy.

Conclusions:

  • Research is increasingly focused on anaesthetic conduct rather than neurotoxicity.
  • Evidence-based findings should be integrated into routine clinical practice.
  • Age-related, patient-centered outcomes are essential for evaluating anaesthesia safety and efficacy in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
56
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
89
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
383
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
57
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
654